MAHA Action's Kyle Warner Briefs TSG Lobbyists as 12-Plus Health Clients Gauge Regulatory Risk
Updated
Updated · POLITICO · Jun 18
MAHA Action's Kyle Warner Briefs TSG Lobbyists as 12-Plus Health Clients Gauge Regulatory Risk
1 articles · Updated · POLITICO · Jun 18
Summary
Kyle Warner, vice president of MAHA Action, is set to give 20-30 minutes of closed-door remarks Thursday at TSG Advocates, followed by questions from lobbyists and clients.
TSG has registered to lobby this year for more than a dozen health care clients, including B. Braun and the Kentucky Hospital Association, as companies try to understand MAHA and find access points into the movement.
That outreach reflects both threat and opportunity: Robert F. Kennedy Jr. has targeted chemicals in food and questioned vaccine safety, while also elevating preventive health and alternative therapies that could benefit some businesses.
For K Street, the lunch shows how the MAHA movement is already generating new business as firms seek protection from regulatory shifts and ways to align with Kennedy's priorities.
Can a health movement succeed when its own administration's policies contradict its core goals?
As agencies challenge medical guidelines, how can parents find trustworthy health advice for their children?
With $600M in U.S. funding cut, what is the fate of global programs vaccinating millions of children?
2026 Health Policy Upheaval: MAHA’s Impact on Vaccines, Food Guidelines, and Regulatory Risk for U.S. Healthcare
Overview
On June 18, 2026, Kyle Warner, VP of MAHA Action, briefed TSG Advocates and health care clients in Washington, D.C., highlighting urgent concerns for the health sector. The MAHA movement, driven by parents seeking medical freedom and access to nontoxic, nutrient-dense food, has gained significant influence with a goal to make vaccine mandates illegal. With Robert F. Kennedy Jr. leading the Department of Health and Human Services, he now holds substantial authority over vaccine research and policymaking. These developments signal potential regulatory shifts that could redefine expectations and create immediate challenges for health sector clients.